Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BRODALUMAB for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where BRODALUMAB was used for Off label use.

Most Reported Side Effects for BRODALUMAB

Side Effect Reports % Deaths Hosp.
Psoriasis 418 20.1% 8 133
Drug ineffective 177 8.5% 2 39
Arthralgia 175 8.4% 3 37
Fatigue 152 7.3% 4 31
Psoriatic arthropathy 141 6.8% 2 18
Intentional product use issue 136 6.5% 7 40
Headache 126 6.1% 4 30
Therapy interrupted 126 6.1% 6 44
Product dose omission issue 124 6.0% 7 57
Disease recurrence 118 5.7% 4 31
Inappropriate schedule of product administration 108 5.2% 1 36
Off label use 99 4.8% 2 34
Diarrhoea 92 4.4% 1 26
Therapy cessation 89 4.3% 2 24
Covid-19 82 3.9% 5 29

Other Indications for BRODALUMAB

Psoriasis (1,595) Product used for unknown indication (284) Psoriatic arthropathy (107) Pustular psoriasis (39) Hidradenitis (24) Product use in unapproved indication (19) Erythrodermic psoriasis (17) Chronic spontaneous urticaria (9) Palmoplantar pustulosis (8) Ankylosing spondylitis (6)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

BRODALUMAB Full Profile All Off label use Drugs BRODALUMAB Demographics BRODALUMAB Timeline